Hepatitis C testing and re-testing among people attending sexual health services in Australia and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data

摘要

BackgroundDirect acting antivirals are expected to drastically reduce the burden of hepatitis C virus (HCV) in people living with Human Immunodeficiency Virus (HIV). However, rates of HCV testing, re-testing and incident infection in this group remain uncertain in Australia. We assessed trends in HCV testing, re-testing and incident infection among HIV-positive individuals, and evaluated factors associated with HCV re-testing and incident infection.